Business Context and Reporting Period
This Form 8-K Current Report was filed by The Clorox Company (CLX) on February 9, 2021. The filing addresses Item 8.01 (Other Events) regarding the adoption of a new corporate governance policy effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is non-financial in nature and focuses exclusively on executive compensation governance.
Material Changes
The primary material change is the adoption of a new "Clawback Policy" by the Management Development and Compensation Committee. This policy applies to incentive compensation granted, promised, or paid to certain current and former executive officers on or after February 9, 2021. The policy consolidates existing clawback provisions found in various compensation plans into a single document without material changes to the underlying terms.
Guidance, Outlook, and Risks
The filing outlines specific conditions under which the Company may recoup incentive compensation:
- Conduct Detrimental to the Company: The Committee may claw back compensation paid to a covered individual up to three years after the end of the year in which it vested or was paid if the individual engages in conduct materially detrimental to the Company's name, business interests, or reputation.
- Financial Restatements: The Committee may recoup incentive compensation paid during the three-year period preceding a restatement announcement if the individual's fraud or intentional misconduct was a significant contributing factor to the restatement.
No financial guidance, outlook, or unusual financial items were disclosed in this filing.
Investor Verification Checklist
- Verify the specific list of "covered individuals" eligible under the new Clawback Policy.
- Review existing compensation agreements to confirm how the new policy integrates with prior clawback provisions.
- Monitor future filings for any application of the policy regarding conduct or financial restatements.